˹

Form: 8-K

Current report filing

March 29, 2024

false 0000944809 0000944809 2024-03-28 2024-03-28


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 28, 2024
˹.
(Exact Name of Registrant as Specified in its Charter)
Delaware
001-33528
75-2402409
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
4400 Biscayne Blvd.
Miami,
Florida
33137
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code: (305)575-4100
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
OPK
NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐



ITEM 5.07.
Submission of Matters to a Vote of Security Holders.
On March 28, 2024, ˹., (the “Company”) held its 2024Annual Meeting of Stockholders (the “Annual Meeting”). Below is a summary of the proposals submitted to a vote of the Company’s stockholders at the Annual Meeting and the corresponding votes.
1. All eleven nominees were elected to the Board of Directors with each director receiving votes as follows:
Election of Directors
For
Against
Abstain
Broker Non-Votes
Phillip Frost, M.D.
417,952,041
22,474,563
6,171,466
84,699,761
Jane H. Hsiao, Ph.D.
413,880,317
26,420,093
6,297,660
84,699,761
Elias A. Zerhouni, M.D.
414,360,287
26,147,182
6,090,601
84,699,761
Steven D. Rubin
409,265,433
31,259,959
6,072,678
84,699,761
Gary J. Nabel, M.D., Ph.D.
414,266,144
26,217,873
6,114,053
84,699,761
Richard M. Krasno, Ph.D.
433,053,909
12,897,229
646,932
84,699,761
Prem A. Lachman, M.D.
435,390,598
10,489,096
718,376
84,699,761
Roger J. Medel, M.D.
435,237,621
10,618,192 742,257 84,699,761
John A. Paganelli
415,788,107
29,404,640 1,405,323 84,699,761
Richard C. Pfenniger, Jr.
419,052,214
26,216,424 1,329,432 84,699,761
Alice Lin-Tsing Yu, M.D., Ph.D.
438,269,264
7,742,819
585,987
84,699,761
2. The stockholders voted to approve an amendment to the Company’s amended and restated certificate of incorporation to increase the authorized number of shares of the Company’s Common Stock that the Company may issue from 1,000,000,000 shares to 1,250,000,000 shares as disclosed in the 2024 Proxy Statement for the Annual Meeting. The votes on the OPKO authorized share increase proposal were as follows:
For
Against
Abstain
492,393,778
37,918,739
985,314
3. The stockholders voted to approve, on a non-binding advisory basis, the compensation of the named executive officers of the Company as disclosed in the Company’s 2024Proxy Statement for the Annual Meeting. The votes on this proposal were as follows:
For
Against
Abstain
Broker Non-Votes
431,121,613.12
13,954,192
1,522,264.675
84,699,761
4. The stockholders voted to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. The votes on this proposal were as follows:
For
Against
Abstain
Broker Non-Votes
519,634,618
10,186,987
1,476,226
0
No other matters were considered or voted upon at the meeting.

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
˹.
By:
/s/ Steven D. Rubin
Date: March 29, 2024
Name:
Steven D. Rubin
Title:
Executive Vice President-Administration